Analyst cuts Lucentis forecast by $1 billion
April 09 2012
Genentech's Lucentis is likely to lose about $1 billion in sales due to competition from an upstart drug and off-label ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.